Connect with us

Business

Should Cannabis Be Part Of Hospice Care?

Published

on

A life-threatening illness is one of the most frightening experiences anyone can go through. No one wants to be diagnosed with a terminal illness, and no one wants someone they love diagnosed with the same thing.  For almost 2 million people each year, they enter hospice for the last part of their life.  It is hard on the patient and the loved ones.  Should cannabis be part of hospice care? In some legal states, hospice staff are allowing marijuana to ease suffering, especially for cancer.

As Americans continue to age, the risks of terminal illnesses increase with more people getting admitted to hospitals and hospices. The Centers for Disease Control (CDC) announced that there are an estimated 1.7+ million people in hospices receiving care from varying life-threatening illnesses. This number is a tremendous increase from what was obtainable in the last 20 years. In those hospices, the patients receive a special kind of care that slows the painful process.

The care given to patients is provided by compassionate individuals who are 100% available to make the last life phases very comfortable. While these hospices are doing their best, there are still instances where some patients don’t get better with the care they receive.

Of course, this is a problematic situation, and it has made medical experts seek solutions for hospices, and marijuana is one of the most viable ideas they explore.

Despite the good intentions, the legal status of marijuana affects its use and effectiveness in hospices. For example, although some states have legalized marijuana, it is still not legally accepted at the federal level. The federal level’s lack of support makes it difficult for some healthcare providers to prescribe cannabis for their patients in hospices.

Marijuana in hospices 

Marijuana is utilized in hospice care to ease patients suffering as it plays a significant therapeutic role for patients dealing with the emotional despair that comes with a terminal illness.

Hospices are turning to marijuana as a way of reinventing their approach to Medicare for patients. These hospices want a more patient-centric care experience that eradicates the idea that they are cold, ineffective, and unwelcome.

Therefore, hospices in America need to incorporate more effective treatment and care options that help them feel like they are making daily progress. In addition to marijuana, the hospices also integrate additional treatment options such as music, thoughtful quality care, and family moments to make the treatment options relatable.

Does Marijuana Have A Place In Hospice?
Photo by Bret Kavanaugh via Unsplash

But medical marijuana has become a new focus for these hospices. As Americans’ attitudes towards marijuana change (from suspicion to acceptance), more hospices are encouraged to consider it as a treatment option.

Currently, 87% of Americans support the utilization of medical marijuana as a treatment option for terminally sick patients. More so, three in five Americans (this is about 58%) express strong support for medical marijuana. So how do hospices use marijuana?

How hospices use marijuana

Primarily, hospices use marijuana as a care treatment alternative to ease the patient’s spiritual and existential suffering. The mild euphoria marijuana offers give the patient a sense of well-being which eases the body, mind, and spirit as they come to terms with the possibility of death.

In 2019, a study showed the impact of cannabis and CBD on hospice and palliative care places, with data drawn from over 300 care professionals from 40 American States. The professionals offered “overwhelming support” for marijuana use in hospices regardless of its legal status in the state.

With such factual details and preference for marijuana in hospices, one can only ask, “How does it help those in the hospices?” Here are answers to that question:

Pain reduction in patients

Pain reduction is one of the most prominent benefits of marijuana used in hospices. The patients sometimes experience excruciating pain, which masks them uncomfortable, making their stay at the hospice unpleasant.

But with medical marijuana treatment, pain is reduced and replaced with a euphoric sensation that eases the patient’s mind, thus making them numb to pain. This health benefit of marijuana can only be effective when the substance is used consistently.

Enhancement of the senses 

Cannabis is an enhancer that heightens patient sensory perceptions and awareness, thus leading to a better appreciation of tastes, senses, and music. Remember that some people in hospices are older individuals who gradually lose their ability to recognize feelings and their sense of taste. But when marijuana is administered, the patient’s sense of awareness is heightened, enabling them to appreciate every moment even as their days are numbered.

Single People In This Age Group Are Having The Best Sex
Photo by Nicole De Khors via Burst

Increases appetite 

The patients in hospices often struggle with their appetite because of the intense treatments (for example, cancer patients). Decreased appetite is also prevalent because they are emotionally down, with the illnesses taking a toll on their mental health. But CBD is an appetite-boosting compound that encourages them to eat regularly and also snack in between meals. A hospice patient will have a greater chance of better managing illness when he or she consistently eats nutritious meals.

Eases anxiety

Anxiety is a common symptom that hospice patients experience due to the fear of death and worries about their families. But when medical marijuana is administered the THC and CBD, it contains impacts such as anxiety levels.

THC, when given in smaller doses, decreases anxiety, and CBD also does the same, thus helping the patient feel relaxed and calm, which provides a significant boost to their health.

Bottom Line 

Medical experts are increasingly excited at the enormous potential of marijuana. Globally, people are beginning to appreciate the value of cannabis. Marijuana products that have been tested and approved for use should be well-integrated into the healthcare system because of their immense benefits.

Experts and caregivers at hospices derive incredible benefits from cannabis. Both of the plant’s recreational and medicinal properties are highly valued by caregivers and patients. However, for marijuana to reach its lofty potential in hospices in the future, there must be a unified legal status of cannabis from federal to state levels.

Until we have such a unified status, marijuana will continue to impact the lives of hospice patients in the ways currently available, helping them manage their terminal illnesses.

Source: https://thefreshtoast.com/medical-marijuana/should-cannabis-be-part-of-hospice-care/

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News